Qualified investors start subscription to Al Razi Medical 304,000 shares today

04/06/2023 Argaam Special
Logo ofAl Razi Medical Co.

Logo of Al Razi Medical Co.


Al Razi Medical Co. starts today, June 4, selling 304,000 shares to qualified investors, in an initial public offering (IPO) on the Nomu-Parallel Market.

 

This represents 20% of Al Razi Medical’s SAR 15.2 million capital, or 1.52 million shares. The price range was set between SAR 24 and SAR 28 per share.

 

The subscription period will run for three days until June 6.

 

With the IPOs of Al Razi Medical and Saudi Call Co., which is also taking place today, offerings on Nomu reach 12 in 2023. Others this year include WAJA Co. on Feb. 12, Bena Steel Industries Co. and KnowledgeNet Co. (Feb. 26), Horizon Food Co. (March 5), Ghida Al-Sultan, and Foods Gate Co. (March 12), as well as Saudi Lime Industries Co., Meyar Co. (March 19), AlMuneef Co. (May 14) and Tam Development Co. (May 21).

 

Nomu saw 19 IPOs last year, including Gas Arabian Services Co., Raoom Trading Co., Al-Jouf Mineral Water Bottling Co., Arabian International Healthcare Holding Co. (Tibbiyah), Arabian Food & Dairy Factories Co. (FADECO), Ladun Investment Co., Amwaj International Co., Saudi Networkers Services Co. (SNS), International Human Resources Co. (IHR), Naba Alsaha Medical Services Co., Arabian Plastic Industrial Co. (APICO), Abdulaziz and Mansour Ibrahim Albabtin Co. (AlBabtain Food), Knowledge Tower Trading Co., Molan Steel Co., Saudi Top Trading Co., Leen Alkhair Trading Co., Nofoth Food Products Co. and Alwaha REIT Fund.

 

The Capital Market Authority (CMA) approved, on April 3, the application submitted by the company to register and offer 304,000 shares on Nomu.

 

The subscription is limited to certain categories of investors, including capital market institutions authorized to act on their own account, as well as clients of capital market institutions authorized to carry out management operations. This is provided that they are appointed under terms that enable them to take decisions related to accepting participation in the share offering and investment in the parallel market on behalf of the clients without prior consent.

 

The categories include the Saudi government, any government body, any international entity approved by the CMA or the Saudi market, or any other financial market recognized by the CMA or the Securities Depository Center (Edaa).

 

They also include companies owned by the government, directly or through a portfolio managed by a market institution authorized to practice management operations, investment funds, in addition to companies and funds established in the GCC countries.

  

The investors qualified to participate in the subscription include non-resident foreigners who are allowed to invest in Nomu, qualified foreign financial institutions, and any legal person entitled to open investment accounts inside the Kingdom and accounts with Edaa.

 

Natural persons are also among the qualified investors allowed to open investment accounts inside the Kingdom and accounts with Edaa, provided they fulfill certain criteria.

 

They should have executed transactions in the securities markets worth a total of no less than SAR 40 million, and no less than 10 deals in each quarter during the past 12 months.

 

Natural persons should also have net assets value of no less than SAR 5 million and be working or have worked for at least three years in the financial sector.

 

They should hold a general certificate in securities dealing, approved by the CMA and a professional certificate in the field of securities business, approved by an internationally-recognized body.

 

The list of qualified investors includes any other persons to be defined by the CMA.

 

Company Info:

 

Al Razi Medical is a closed joint stock company established as a sole proprietorship in 2006 in Al Badayea city, Al-Qassim Region.

 

Operating in the pharmacies activities segment, Al Razi Medical’s activities include storage, sale and marketing of medicines and medical, cosmetic and pharmaceutical products.

 

Company Profile

Company

 Al Razi Medical Co.

Market

Nomu-Parallel Market

Core activities

Pharmacy activities

Capital

SAR 15.2 mln

 

IPO Summary

Issue Percentage

20%

Offered shares

304,000 

Minimum limit

10 shares

Maximum limit

74,000 shares

Offer period

June 4-6, 2023

Final Allocation

June 11, 2023

Refund (if any)

June 12, 2023

 

Company Shareholders

Shareholders

Pre-IPO

Post-IPO

Number of Shares

(‘000)

Ownership (%)

Number of Shares

(‘000)

Ownership (%)

Yousuf Abdullah Yousuf Al Arini

1141.9

75.1%

994.9

65.5%

Mohammed Abdullah Suleiman Al Saghir

29.2

1.9%

6.9

0.5%

Fawziya Suleiman Abdullah Al Saghir

24.0

1.6%

13.9

0.9%

Mohammed Abdullah Suleiman Ebeid

22.1

1.5%

12.8

0.8%

Others

302.8

19.9%

187.5

12.3%

QFIs

--

--

304.0

20.0%

Total

1520.0

100%

1520.0

100%

 

Additional Information

Financial Advisor  

Team One Co.

Lead Manager

Derayah Financial

 

 

For More IPOs

Comments {{getCommentCount()}}

Be the first to comment

loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.